---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-011974"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2024-09-16T23:59:59+00:00"
generated_at: "2026-05-31T04:30:09.030288+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv Q3 revenue falls to $2.4M, swings to net loss of $0.3M

## Summary
- Q3 revenue $2.4M, down ~$2.2M (48%) from $4.6M in same quarter last year.
- Net loss of $0.3M compared to net income of $0.5M in Q3 last year.
- Nine-month revenue $7.2M (down $6.2M); net loss $0.8M vs net income $1.4M.
- CEO cites challenging investment environment; investing in tech tools to return to profitability.

## SEC filing metadata
- accession: 0001654954-24-011974
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2024-09-16T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495424011974/0001654954-24-011974-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495424011974/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-011974
- JSON: https://secwatch.observer/filing/0001654954-24-011974.json
- Plain text: https://secwatch.observer/filing/0001654954-24-011974.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.